Chun‐Shu Lin

2.0k total citations
87 papers, 1.4k citations indexed

About

Chun‐Shu Lin is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chun‐Shu Lin has authored 87 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 24 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chun‐Shu Lin's work include Head and Neck Cancer Studies (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Chun‐Shu Lin is often cited by papers focused on Head and Neck Cancer Studies (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Chun‐Shu Lin collaborates with scholars based in Taiwan, United Kingdom and United States. Chun‐Shu Lin's co-authors include Hsing‐Lung Chao, Wen‐Yen Huang, Yee‐Min Jen, Cheng‐Hsiang Lo, Kuen‐Tze Lin, Jen-Fu Yang, Ming‐Fang Cheng, Shao‐Cheng Liu, Chi‐Tai Yeh and Jing‐Min Hwang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Chun‐Shu Lin

81 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun‐Shu Lin Taiwan 23 374 371 362 330 304 87 1.4k
Ki Mun Kang South Korea 20 288 0.8× 413 1.1× 347 1.0× 162 0.5× 501 1.6× 71 1.4k
Alejandra Romero Spain 13 213 0.6× 767 2.1× 371 1.0× 182 0.6× 529 1.7× 20 1.6k
Hyun Ju Kim South Korea 16 201 0.5× 169 0.5× 250 0.7× 299 0.9× 355 1.2× 50 1.2k
Francesco Fiorica Italy 23 70 0.2× 909 2.5× 1.1k 3.1× 285 0.9× 1.1k 3.6× 95 2.3k
Carmela Romano Italy 20 113 0.3× 307 0.8× 199 0.5× 231 0.7× 449 1.5× 76 1.5k
J. S. Lee United States 15 53 0.1× 1.2k 3.2× 192 0.5× 354 1.1× 728 2.4× 20 1.8k
M Forni France 19 70 0.2× 458 1.2× 299 0.8× 526 1.6× 1.1k 3.6× 39 1.8k
Michela Del Prete Italy 25 203 0.5× 369 1.0× 303 0.8× 362 1.1× 857 2.8× 75 1.9k
Thierry Muanza Canada 21 20 0.1× 694 1.9× 205 0.6× 380 1.2× 382 1.3× 68 1.6k
Angelica Petrillo Italy 19 138 0.4× 350 0.9× 237 0.7× 233 0.7× 551 1.8× 68 1.1k

Countries citing papers authored by Chun‐Shu Lin

Since Specialization
Citations

This map shows the geographic impact of Chun‐Shu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Shu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Shu Lin more than expected).

Fields of papers citing papers by Chun‐Shu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Shu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Shu Lin. The network helps show where Chun‐Shu Lin may publish in the future.

Co-authorship network of co-authors of Chun‐Shu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Shu Lin. A scholar is included among the top collaborators of Chun‐Shu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Shu Lin. Chun‐Shu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lo, Cheng‐Hsiang, Yu–Fu Su, Jen-Fu Yang, et al.. (2024). Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell Carcinoma. JCO Precision Oncology. 8(8). e2400555–e2400555. 1 indexed citations
3.
Su, Yu–Fu, Chun‐Shu Lin, Shuang‐En Chuang, et al.. (2023). MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway. Journal of Dental Sciences. 19(1). 428–437. 5 indexed citations
4.
Huang, Wen‐Yen, et al.. (2022). Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data. Japanese Journal of Clinical Oncology. 52(9). 992–1000. 3 indexed citations
6.
Huang, Wen‐Yen, et al.. (2021). Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 8. 1299–1309. 10 indexed citations
7.
Lo, Cheng‐Hsiang, et al.. (2021). Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy. npj Genomic Medicine. 6(1). 40–40. 27 indexed citations
8.
Kuo, Chung‐Feng Jeffrey, et al.. (2020). <p>Quantitative Morphometric Measurements of the Oropharynx in Obstructive Sleep Apnea Syndrome Using a Laser Depth Measurement Module</p>. Nature and Science of Sleep. Volume 12. 1181–1190. 2 indexed citations
9.
Liu, Shao‐Cheng, Oluwaseun Adebayo Bamodu, Chi‐Tai Yeh, et al.. (2019). Ovatodiolide suppresses inflammatory response in BEAS-2B cells by regulating the CREB/AQP5 pathway, and sensitizes nasopharyngeal carcinoma cells to radiation therapy. European Journal of Pharmacology. 859. 172548–172548. 11 indexed citations
10.
Chang, Ping‐Ying, Chi‐Hsiang Chung, Wei‐Chou Chang, et al.. (2019). The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study. PLoS ONE. 14(5). e0216828–e0216828. 20 indexed citations
12.
Lee, Shih‐Yu, Wei‐Kuo Chang, Kuen‐Tze Lin, et al.. (2018). Risk of gastric cancer following percutaneous endoscopic gastrostomy: A nationwide population-based cohort study. Medical Hypotheses. 118. 93–97.
13.
Lin, Chun‐Shu, Oluwaseun Adebayo Bamodu, Kuang-Tai Kuo, et al.. (2018). Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit. Phytomedicine. 46. 93–103. 24 indexed citations
14.
Yang, Cheng‐Yu, Cheng‐Chih Hsieh, Chih‐Kung Lin, et al.. (2017). Danshen extract circumvents drug resistance and represses cell growth in human oral cancer cells. BMC Complementary and Alternative Medicine. 17(1). 555–555. 16 indexed citations
15.
Lo, Cheng‐Hsiang, Jen-Fu Yang, Yee‐Min Jen, et al.. (2017). Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy. PLoS ONE. 12(5). e0177793–e0177793. 21 indexed citations
16.
Chang, Wei‐Kuo, Kuen‐Tze Lin, Chen‐Liang Tsai, et al.. (2016). Trends regarding percutaneous endoscopic gastrostomy. Medicine. 95(24). e3910–e3910. 12 indexed citations
17.
Lin, Chun‐Shu, Ying‐Chin Lin, Oluwaseun Adebayo Bamodu, et al.. (2015). Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. Cancer Letters. 368(1). 36–45. 50 indexed citations
18.
Chang, Wei‐Chou, Kai‐Hsiung Ko, Chun‐Shu Lin, et al.. (2014). Features on MDCT That Predict Surgery in Patients with Adhesive-Related Small Bowel Obstruction. PLoS ONE. 9(2). e89804–e89804. 25 indexed citations
19.
Lin, Hon‐Yi, Chih‐Hung Ku, Dai‐Wei Liu, et al.. (2009). Hyperbaric Oxygen Therapy for Late Radiation-Associated Tissue Necroses: Is It Safe in Patients With Locoregionally Recurrent and Then Successfully Salvaged Head-and-Neck Cancers?. International Journal of Radiation Oncology*Biology*Physics. 74(4). 1077–1082. 8 indexed citations
20.
Chao, Hsing‐Lung, et al.. (2005). Unusual distant metastatic lesion from buccal carcinoma mimics refractory gouty arthritis. 41(10). 303–305. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026